Genelux (GNLX) Shares Issued (2022 - 2026)
Genelux's (GNLX) quarterly Shares Issued came in at $4.3 million in Q1 2026, down 35.38% quarter-over-quarter from $6.7 million in Q4 2025.
Genelux (GNLX) Shares Issued (2022 - 2026) Analysis & Trends
Genelux's Shares Issued history runs 5 years deep, the most recent figure standing at $4.3 million for Q1 2026.
- On a quarterly basis, Shares Issued changed N/A year-over-year to $4.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $6.7 million, up 24.87% from the prior year.
- Shares Issued retreated to $4.3 million in Q1 2026 per GNLX's latest filing, from $6.7 million in the prior quarter.
- Across five years, Shares Issued topped out at $6.7 million in Q4 2025 and bottomed at $2.8 million in Q3 2022.
- The 5-year median for Shares Issued is $4.2 million (2025), against an average of $4.5 million.
- Across the five-year window, Shares Issued surged 82.29% in 2023 and declined 25.93% in 2024, its largest moves.
- Year by year, Shares Issued stood at $4.2 million in 2022, then advanced by 21.85% to $5.1 million in 2023, then climbed by 5.01% to $5.4 million in 2024, then grew by 24.87% to $6.7 million in 2025, then slumped by 35.38% to $4.3 million in 2026.
- Per Business Quant, the three latest GNLX Shares Issued figures stand at $4.3 million (Q1 2026), $6.7 million (Q4 2025), and $4.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 154.50 Mn |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | - |
| 10 | Genelux | 128.48 Mn | 128.48 Mn | - | 4.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.34 Mn |
| Mar 31, 2026 | 4.34 Mn |
| Dec 31, 2025 | 6.71 Mn |
| Dec 31, 2025 | 6.71 Mn |
| Sep 30, 2025 | 4.21 Mn |
| Sep 30, 2025 | 4.21 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Dec 31, 2024 | 5.38 Mn |
| Dec 31, 2024 | 5.38 Mn |
| Sep 30, 2024 | 3.78 Mn |
| Sep 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 5.12 Mn |
| Mar 31, 2024 | 5.12 Mn |
| Dec 31, 2023 | 5.12 Mn |
| Dec 31, 2023 | 5.12 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Sep 30, 2023 | 5.10 Mn |